All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • INV-9956Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advanced Metastatic Castration Resistant Prostate Cancer

  • 4TEEN4 Pharmaceuticals GmbH · Shock, Cardiogenic

  • INX-315Phase 21 trial

    Incyclix Bio · Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor

  • IO-108Phase 21 trial

    Roche (Genentech) · Advanced Liver Cancers

  • ION337Phase 21 trial

    Ionis Pharmaceuticals · Dravet Syndrome

  • ION440Phase 21 trial

    Ionis Pharmaceuticals · Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

  • ION717Phase 21 trial

    Ionis Pharmaceuticals · Prion Disease

  • ION775Phase 21 trial

    Ionis Pharmaceuticals · Hypertriglyceridemia, Severe Hypertriglyceridemia

  • IOV-3001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma

  • IOV-4001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer

  • IOV-5001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)

  • IPG1094Phase 21 trial

    Nanjing Immunophage Biotech Co., Ltd · Solid Tumor

  • IPH5201Phase 21 trial

    Innate Pharma · Non Small Cell Lung Cancer

  • IPN01194Phase 21 trial

    Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma

  • IPN01195Phase 21 trial

    Ipsen · Advanced Solid Tumor

  • IPN01203Phase 21 trial

    Ipsen · Advanced Solid Tumor, Metastatic Solid Tumor

  • IPN60300Phase 21 trial

    Ipsen · Locally Advanced Solid Tumor, Metastatic Solid Tumor

  • IPN60350Phase 21 trial

    Ipsen · Neoplasms, Neoplasm Metastasis, Neoplastic Processes

  • IRL757Phase 21 trial

    Integrative Research Laboratories AB · PARKINSON DISEASE (Disorder), Apathy, Safety

  • iscalimabCFZ533Phase 21 trial

    Novartis · Hidradenitis Suppurativa

  • ISLA101fenretinidePhase 21 trial

    Island Pharmaceuticals · Dengue

  • ISM3412Phase 21 trial

    InSilico Medicine Hong Kong Limited · Locally Advanced/Metastatic Solid Tumors

  • ISM6331Phase 21 trial

    InSilico Medicine Hong Kong Limited · Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor

  • ITU512Phase 21 trial

    Novartis · Sickle Cell Disease

  • IvaltinostatPhase 21 trial

    CG Pharmaceuticals, Inc · Metastatic Pancreatic Adenocarcinoma

  • IVIEW-1201Phase 21 trial

    IVIEW Therapeutics Inc. · Fungal Keratitis

  • IVL3003Phase 21 trial

    Inventage Lab., Inc. · Alzheimer Disease

  • IVMED-85Phase 21 trial

    iVeena Delivery Systems, Inc. · Myopia, Progressive

  • IW-6463CY6463, zagociguatPhase 21 trial

    Tisento Therapeutics · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)

  • JAB-2485Aurora A inhibitorPhase 21 trial

    Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC

  • JAB-30355Phase 21 trial

    Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors

  • JB100Phase 21 trial

    EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma

  • JBI-778Phase 21 trial

    Jubilant Therapeutics Inc. · Brain Metastases From Solid Tumors, Leptomeningeal Disease, High Grade Glioma (HGG)

  • JBI-802Phase 21 trial

    Jubilant Therapeutics Inc. · Essential Thrombocythemia (ET), Polycythemia Vera

  • JCXH-105Phase 21 trial

    Immorna Biotherapeutics, Inc. · Herpes Zoster (HZ), Infectious Diseases, Shingles

  • JDB0131Phase 21 trial

    WestVac Biopharma Co., Ltd. · Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis

  • JK06Phase 21 trial

    Salubris Biotherapeutics Inc · Solid Tumor

  • JK07Phase 21 trial

    Salubris Biotherapeutics Inc · Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction

  • JKN2304Phase 21 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease), COPD

  • JKN24011Phase 21 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease)

  • JKN2403Phase 21 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease)

  • JL15003InjectionPhase 21 trial

    Jecho Biopharmaceuticals Co., Ltd. · Recurrent Glioblastoma Multiforme(GBM)

  • JL18008Phase 21 trial

    Jecho Biopharmaceuticals Co., Ltd. · HIV Infections

  • JMBI-001Phase 21 trial

    Chengdu Anticancer Bioscience, Ltd. · Advance Solid Tumors, Lymphoma, Non-Hodgkin

  • JMKX000197Phase 21 trial

    Shanghai Jeyou Pharmaceutical Co., Ltd. · Malignant Pleural Effusions (Mpe)

  • JMT202Phase 21 trial

    Shanghai JMT-Bio Inc. · Hypertriglyceridemia

  • JMT203Phase 21 trial

    Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia

  • JMT601Phase 21 trial

    Shanghai JMT-Bio Inc. · Primary Membranous Nephropathy

  • JNJ-64042056Phase 21 trial

    Johnson & Johnson (Janssen) · Alzheimer Disease

  • JNJ-88545223Phase 21 trial

    Johnson & Johnson (Janssen) · Arthritis, Psoriatic

NewerPage 58 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.